U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414316) titled 'A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.' on Feb. 05.
Brief Summary: A Single-Center, Open-Label Clinical Study to Evaluate the Safety, Preliminary Efficacy of GK01 Cell Injection in Subjects with Advanced Solid Tumors Refractory or Intolerant to Standard Therapy
Study Start Date: Feb. 13
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: GK01 Injection
Autologous tumor-reactive T cells injection
Recruitment Status: RECRUITING
Sponsor: Beijing Geekgene Technology Co., LTD
Published by HT Digital Content Services with permission from Hea...